Literature DB >> 11844855

Drug-induced autoimmune red-cell aplasia.

H Franklin Bunn.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11844855     DOI: 10.1056/NEJM200202143460711

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

1.  Micelle-associated protein in epoetin formulations: aA risk factor for immunogenicity?

Authors:  Suzanne Hermeling; Huub Schellekens; Daan J A Crommelin; Wim Jiskoot
Journal:  Pharm Res       Date:  2003-12       Impact factor: 4.200

Review 2.  Structure-immunogenicity relationships of therapeutic proteins.

Authors:  Suzanne Hermeling; Daan J A Crommelin; Huub Schellekens; Wim Jiskoot
Journal:  Pharm Res       Date:  2004-06       Impact factor: 4.200

3.  Role of hematopoietic growth factors as adjuncts in the treatment of chronic hepatitis C patients.

Authors:  Fazal A Danish; Salman S Koul; Fazal R Subhani; Ahemd E Rabbani; Saeeda Yasmin
Journal:  Saudi J Gastroenterol       Date:  2008-07       Impact factor: 2.485

4.  Antierythropoietin antibody-induced pure red cell aplasia: posttransplant evolution.

Authors:  Angel Alonso Melgar; Marta Melgosa Hijosa; Rafael Pardo de la Vega; Carmen García Meseguer; Mercedes Navarro Torres
Journal:  Pediatr Nephrol       Date:  2004-05-07       Impact factor: 3.714

5.  A 46-Year-Old Thai Woman with Secondary Acquired Pure Red Cell Aplasia Due to Treatment with Recombinant Erythropoietin While on Dialysis for End-Stage Renal Disease Who Recovered Following ABO-Incompatible Kidney Transplantation.

Authors:  Rungthiwa Kitpermkiat; Sansanee Thotsiri; Nuttaporn Arpornsujaritkun; Premsant Sangkum; Pichika Chantrathammachart; Pimpun Kitpoka; Duangtawan Thammanichanond; Tanist Virankabutra; Surasak Kantachuvesiri
Journal:  Am J Case Rep       Date:  2022-07-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.